Ally is an AI-driven platform that customizes clinical trial operations by securely managing workflows and documents, ensuring that control remains with the user. The solution enhances the efficiency and accessibility of clinical research for global teams and participants, addressing the complexities of trial management.
Funding
$100K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Clinical trial operations involve complex workflows and extensive documentation, creating inefficiencies for global teams and hindering accessibility for participants. Managing these complexities while maintaining security and control over sensitive data presents a significant challenge.
Solution
Ally is an AI-powered platform designed to streamline and customize clinical trial operations. The platform securely manages workflows and documents, ensuring users retain complete control over their data. By leveraging AI, Ally enhances the efficiency and accessibility of clinical research for both global teams and participants, simplifying the complexities inherent in trial management. The platform is custom-trained on specific procedures and documents, providing a tailored solution for each clinical trial's unique needs.
Target Audience
Ally is designed for clinical operations teams, research institutions, and pharmaceutical companies seeking to improve the efficiency and security of their clinical trials.
Features
- AI-driven workflow automation for clinical trial processes
- Secure document management with user-controlled access
- Custom training on specific clinical trial procedures and documentation
- Streamlined communication and collaboration tools for global teams
- Enhanced accessibility features for clinical trial participants